A Study of EMB-02 in Participants With Advanced Solid Tumors

Clinical trial NCT04618393 · TERMINATED

Trial details

NCT number: NCT04618393
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2021-03-11
Primary completion: 2023-07-12
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.